jain.com
The Analysis · Companies · People · Methodology

Convertible Senior Notes Issuance

Company: IREN

This claim was withdrawn on September 3, 2026. The filing states the $50 million option exercise is included within the $550 million principal amount issued, not additive to it, so the claimed $600 million total is wrong.

How this was decided: Evidence review against the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2025-06-12
Promised by
2029-12-15
Promised amount
600.0 USD
Current status
withdrawn

The claim, verbatim

IREN issued $550 million in 3.50% Convertible Senior Notes due 2029, with an additional $50 million issued pursuant to initial purchasers' option exercise, for a total of $600 million principal amount

Source (primary)

IREN 6-K filed 2025-06-13 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “IREN Limited (the "Company") issued $550 million principal amount of its 3.50% Convertible Senior Notes due 2029... The Convertible Notes issued on June 13, 2025 include $50 million principal amount of Convertible Notes issued pursuant to the full exercise by the initial purchasers of such option.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms IREN 6-K filed 2025-06-13

Quote: “IREN Limited (the "Company") issued $550 million principal amount of its 3.50% Convertible Senior Notes due 2029... The Convertible Notes issued on June 13, 2025 include $50 million principal amount of Convertible Notes issued pursuant to the full exercise by the initial purchasers of such option.”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 2, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 3, 2026 — withdrawn
Evidence review against the cited source. The filing states the $50 million option exercise is included within the $550 million principal amount issued, not additive to it, so the claimed $600 million total is wrong.